Issue 33, 2018

Localized cancer treatment by radio-frequency hyperthermia using magnetic nanoparticles immobilized on graphene oxide: from novel synthesis to in vitro studies

Abstract

We have produced an innovative, theranostic hybrid nanocomposite of graphene oxide and iron oxide (GO–Fe3O4) for radio-frequency hyperthermia therapy. A new electrochemical synthesis route for the GO–Fe3O4 nanocomposite is employed. Superparamagnetic nanoparticles used for magnetic hyperthermia for biomedical application face longstanding obstacles, including the large number of nanoparticles required to achieve the desired therapeutic temperature, poor colloidal stability in aqueous suspension or physiological media, poor biocompatibility and, most importantly, low specific absorption rate (SAR). To limit the dosage of nanoparticles for therapeutic use, efforts are being made to increase the heating efficiency of nanoparticles. We have introduced an alternative way to increase the SAR value by improving the colloidal stability of magnetic nanoparticles. It is necessary to immobilize these nanoparticles on a support to prevent their agglomeration and precipitation in aqueous suspension. To address these issues, we report a reproducible electrochemical synthesis route for the GO–Fe3O4 nanocomposite. Our nanocomposite demonstrated good colloidal stability and low cytotoxicity in vitro. Due to its good colloidal stability, the nanocomposite had a high SAR of 543 W g−1 and corresponding intrinsic loss power of 5.98 nH m2 kg−1, which is 46% better than the best commercial equivalents. In vitro cytotoxicity studies demonstrated almost 70% cell viability at 200 μg mL−1 GO–Fe3O4 nanocomposite, a comparable concentration for clinical use according to FDA standards. We also showed the therapeutic potential of the nanocomposite using magnetic hyperthermia. We observed cancer cell (A549 human lung epithelial adenocarcinoma) ablation at 41, 42 and 43 °C for 30, 45, and 60 min. A maximum cancer cell death rate of 80.5% was observed at 43 °C for 60 min under alternating magnetic field exposure. Thus, the nanocomposites could be used in the efficient treatment of cancer.

Graphical abstract: Localized cancer treatment by radio-frequency hyperthermia using magnetic nanoparticles immobilized on graphene oxide: from novel synthesis to in vitro studies

Article information

Article type
Paper
Submitted
24 May 2018
Accepted
25 Jul 2018
First published
25 Jul 2018

J. Mater. Chem. B, 2018,6, 5385-5399

Localized cancer treatment by radio-frequency hyperthermia using magnetic nanoparticles immobilized on graphene oxide: from novel synthesis to in vitro studies

R. Kumar, A. Chauhan, S. K. Jha and B. K. Kuanr, J. Mater. Chem. B, 2018, 6, 5385 DOI: 10.1039/C8TB01365A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements